Epsilon M&A Deal Report - Laboratoires Majorelle
Transaction Multiples for the Valuation of Private Companies
Private Group led by EW Healthcare Partners / Laboratoires Majorelle
No EMAT :
109837
Announced Date :
30/04/2021
Type :
MBO (Management Buy Out)
Deal Value :
Yes
Acquirer :
Private Group led by EW Healthcare Partners
Target :
Laboratoires Majorelle
Country :
Paris
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Founded in 2012 by Mehdi El Glaoui, Laboratoires Majorelle is a French specialty pharma company focused on prescription and OTC products in women’s health and urology that offer health solutions for...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 128
| Date | Acquirer | Target | Country | Multiples | See details |
| 18/06/2021 | Ethypharm | Altan Pharma | Ireland | *** | 109827 |
| 25/11/2021 | Medios | NewCo Pharma Group | Germany | ** | 109809 |
Source: Epsilon Research / EMAT
